Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting

Blood

Volumn 102, Issue 3, 2003, Pages 834-838

  Rahimy, Mohamed Cherif ^a   Gangbo, Annick ^a   Ahouignan, Gilbert ^a   Adjou, Roselyn ^a   Deguenon, Chantal ^a   Goussanou, Stephanie ^a   Alihonou, Eusebe ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FOLIC ACID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; PENICILLIN G; PNEUMOCOCCUS VACCINE; TYPHOID VACCINE;

AFRICA; ARTICLE; BLOOD TRANSFUSION; CAUSE OF DEATH; CHILD; CHILD GROWTH; CHILD HEALTH CARE; CHILD NUTRITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH STATUS; HUMAN; IMMUNIZATION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL CARE; PARENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; SICKLE CELL ANEMIA;

EID: 0043245973     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1453     Document Type: Article

References (23)

1. Serjeant GR. The clinical features of sickle cell disease. In: Higgs D, Weatherall DJ, eds. The Haemoglobinopathies: Bailliere's Clinical Haematology. Vol 6. London, United Kingdom: Bailliere Tindall. 1993:93-115.
2. Embury SH, Hebbel RP, Mohandas N, Steinberg MH. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994.
3. Jackson JF, Odom JL, Bell WN. Amelioration of sickle disease by persistent fetal hemoglobin. JAMA. 1961;177:867-869.
4. Embury SH, Dozy AM, Miller J, et al. Concurrent sickle cell anemia and alpha-thalassemia: effect on severity of anemia. N Engl J Med. 1982;306:270-274.
5. Perrine RP, Pembrey ME, John P, Perrine S, Shoup F. Natural history of sickle cell anemia in Saudi Arabs. Ann Int Med. 1978;88:1-6.
6. Brittenham G, Lozoff B, Harris JW, Sharma VS, Narasimhan S. Sickle cell anemia and trait in a population of Southern India. Am J Hematol. 1977;2:25-32.
7. Pagnier J, Mears JG, Dunda-Belkhodja O, et al. Evidence for the multicentric origin of the sickle hemoglobin gene in Africa. Proc Natl Acad Sci U S A. 1984;81:1771-1773.
8. Kulozik AE, Wainscoat JS, Serjeant GR, et al. Geographical survey of betaS-globin gene haplo-types: evidence for an independent Asian origin of the sickle-cell mutation. Am J Hum Genet. 1986;9:239-244.
9. Lapoumeroulie C, Dunda O, Ducrocq R, et al. A novel sickle cell mutation of yet another origin in Africa: the Cameroon type. Hum Genet. 1992;89:333-337.
10. Vichinsky E, Hurst D, Earles A, et al. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988;81:749-755.
11. Githens JH, Lane PA, McCurdy RS, et al. New-born screening for hemoglobinopathies in Colorado. Am J Dis Child. 1990;144:466-470.
12. Clinical Practices Guideline Number 6: Sickle cell disease: screening, diagnosis, management and counseling in newborn and infants. Rockville, MD: Agency for Health Care Policy and Research (AHCPR), US Department of Health and Human Services; 1993. AHCPR publication 93-0562.
13. Serjeant GR, Serjeant BE. Management of sickle cell disease: lessons from the Jamaican cohort study. Blood. 1993;7:137-145.
14. Hendrickse RG, Bames PM. Sickle cell anaemia: report of a therapeutic trial. West Afr Med J. 1966;4:55-64.
15. Serjeant GR. Sickle Cell Disease. 2nd ed. Oxford, United Kingdom: Oxford University Press; 1992:477.
16. Rahimy MC, Gangbo A, Ahouignan G, Anagnou S, Boco V. Outpatient management of fever in children with sickle cell disease in an African setting. Am J Hematol. 1999;62:1-6.
17. Serjeant GR. Sickle cell disease. Lancet. 1997;350:725-730.
18. Badaloo A, Jackson AA, Jahoor F. Whole body protein turnover and resting metabolic rate in homozygous sickle cell disease. Clin Sci. 1989;77:93-97.
19. Singhal A, Davies P, Sahota A, Thomas PW, Serjeant GR. Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr. 1993;57:32-34.
20. Salman EK, Haymond MW, Bayne E, et al. Protein and energy metabolism in pre-pubertal children with sickle cell anemia. Pediatr Res. 1996;40:34-40.
21. Singhal A, Davies P, Wierenga KJJ, Thomas PW, Serjeant GR. Is there an energy deficiency in homozygous sickle cell disease? Am J Clin Nutr. 1997;66:386-390.
22. Barden EM, Zemel BS, Kawchak DA, et al. Total and resting energy expenditure in children with sickle cell disease. J Pediatr. 2000;136:73-79.
23. Rahimy MC, Gangbo A, Adjou R, Deguenon C, Alihonou E. Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting. Blood. 2000;96:1685-1689.